Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: a review of potential benefits and possible adverse reactions
M Moser
Yale University School of Medicine, New Haven, Connecticut, USA.
A review of recent studies suggests that the use of angiotensin-converting enzyme (ACE) inhibitors may be preferred (usually along with a diuretic drug) as initial therapy in several subsets of hypertensive patients (i.e., those with diabetes and nephropathy or with diminished left ventricular function with or without symptoms of heart failure). Limited long-term data are available for the angiotensin II receptor antagonists. The use of nondihydropyridine calcium channel blocking agents (CCBs) appears to reduce reinfarction in patients with ischemic heart disease (however, mortality is not reduced). Long-acting formulas of CCBs appear to decrease congestive heart failure in patients with dilated, but not ischemic, cardiomyopathy and to decrease strokes and arrhythmias in hypertensive subjects. Short-acting agents (primarily those that increase heart rate) may increase coronary heart disease events in hypertensive patients. There is little evidence at present that CCBs offer a major advantage over other antihypertensive agents or that they should be recommended as initial therapy, except in special situations.
This article has been cited by other articles:
|
|
|
|
 
Y. J. Oh, J. H. Lee, S. B. Nam, J. K. Shim, J. H. Song, and Y. L. Kwak
Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass
Br. J. Anaesth.,
December 1, 2006;
97(6):
792 - 798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. F. Hou, X. Zhang, G. H. Zhang, D. Xie, P. Y. Chen, W. R. Zhang, J. P. Jiang, M. Liang, G. B. Wang, Z. R. Liu, et al.
Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
N. Engl. J. Med.,
January 12, 2006;
354(2):
131 - 140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Remuzzi, P. Ruggenenti, A. Perna, B. D. Dimitrov, D. de Zeeuw, D. A. Hille, S. Shahinfar, G. W. Carides, B. M. Brenner, and for the RENAAL Study Group
Continuum of Renoprotection with Losartan at All Stages of Type 2 Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL Trial Results
J. Am. Soc. Nephrol.,
December 1, 2004;
15(12):
3117 - 3125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. T. Lackland, B. M. Egan, H. E. Syddall, and D. J.P. Barker
Associations Between Birth Weight and Antihypertensive Medication in Black and White Medicaid Recipients
Hypertension,
January 1, 2002;
39(1):
179 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ruggenenti, A. Perna, and G. Remuzzi
ACE Inhibitors to Prevent End-Stage Renal Disease: When to Start and Why Possibly Never to Stop: A Post Hoc Analysis of the REIN Trial Results
J. Am. Soc. Nephrol.,
December 1, 2001;
12(12):
2832 - 2837.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Moser
Is It Time for a New Approach to the Initial Treatment of Hypertension?
Arch Intern Med,
May 14, 2001;
161(9):
1140 - 1144.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Xie, Z. Qu, A. Garfinkel, and J. N. Weiss
Electrophysiological heterogeneity and stability of reentry in simulated cardiac tissue
Am J Physiol Heart Circ Physiol,
February 1, 2001;
280(2):
H535 - H545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bertrand, G. Godet, K. Meersschaert, L. Brun, E. Salcedo, and P. Coriat
Should the Angiotensin II Antagonists be Discontinued Before Surgery?
Anesth. Analg.,
January 1, 2001;
92(1):
26 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Grace and A.J. Camm
Voltage-gated calcium-channels and antiarrhythmic drug action
Cardiovasc Res,
January 1, 2000;
45(1):
43 - 51.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Brabant, M. Bertrand, D. Eyraud, P.-L. Darmon, and P. Coriat
The Hemodynamic Effects of Anesthetic Induction in Vascular Surgical Patients Chronically Treated with Angiotensin II Receptor Antagonists
Anesth. Analg.,
December 1, 1999;
89(6):
1388 - 1388.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Y. Reaves, C. H. Gelband, H. Wang, H. Yang, D. Lu, K. H. Berecek, M. J. Katovich, and M. K. Raizada
Permanent Cardiovascular Protection From Hypertension by the AT1 Receptor Antisense Gene Therapy in Hypertensive Rat Offspring
Circ. Res.,
November 12, 1999;
85
(10):
e44 - e50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Golomb and M. H. Criqui
Antihypertensives: Much Ado About Lipids
Arch Intern Med,
March 22, 1999;
159(6):
535 - 537.
[Full Text]
[PDF]
|
|
|
|
